Dyett John
CIK: 0001610631
Associated companies
Transaction History
| FEMY | ▼ Sell | Other | 3,219,795 | $0 | 12/15/2021 | View on chart |
| FEMY | ▼ Sell | Other | 175,635 | $0 | 12/15/2021 | View on chart |
| FEMY | ▼ Sell | Other | 3,219,795 | $0 | 12/15/2021 | View on chart |
| FEMY | ▼ Sell | Other | 175,635 | $0 | 12/15/2021 | View on chart |
We use analytics to understand how market-wall is used. No personal data is sold.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 9, 2026
Femasys to Showcase FemaSeed at ASRM 2026
Femasys announced it will exhibit its FemaSeed fertility treatment at the ASRM 2026 Scientific Congress & Expo. This move signals an expansion of the company's commercialization strategy as it seeks to increase visibility for its product. The stock currently trades near its 52-week low, with an RSI of 36.7 indicating recent weakness.
Femasys to Showcase FemaSeed at ASRM 2026. Femasys announced it will exhibit its FemaSeed fertility treatment at the ASRM 2026 Scientific Congress & Expo. This move signals an expansion of the company's commercialization strategy as it seeks to increase visibility for its product. The stock currently trades near its 52-week low, with an RSI of 36.7 indicating recent weakness.